Harmony Biosciences Holdings Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Harmony Biosciences Holdings, Inc. (HRMY) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents453.00311.66323.12234.31228.63
Short-Term Investments14.1941.8079.330.000.00
Cash & Short-Term Investments467.19353.46323.12234.31228.63
Accounts Receivable83.0374.1454.7434.8422.18
Inventory7.205.364.304.433.82
Other Current Assets13.7112.578.793.226.96
Total Current Assets579.25451.07400.29284.44262.89
Non-Current Assets
Property, Plant & Equipment (Net)3.382.720.570.820.94
Long-Term Investments108.8772.1722.570.000.00
Intangible Assets113.26137.11160.95143.92162.34
Other Non-Current Assets4.034.223.554.270.90
Total Non-Current Assets419.95360.38273.59149.00164.18
Total Assets999.20811.45673.87433.44427.07
Current Liabilities
Accounts Payable13.7417.733.7950.422.56
Short-Term Debt16.2515.002.002.000.00
Current Portion of Long-Term Debt16.2515.002.002.000.00
Accrued Liabilities139.42123.2459.9440.2531.67
Other Current Liabilities4.356.3713.161.36100.31
Total Current Liabilities175.08163.7878.8853.78134.54
Non-Current Liabilities
Long-Term Debt163.02178.57189.65189.98194.25
Other Non-Current Liabilities1.131.0362.443.181.11
Total Non-Current Liabilities164.96180.68192.15193.16195.36
Total Liabilities340.05344.46271.03246.94329.89
Stockholders' Equity
Common Stock0.000.000.000.000.00
Retained Earnings2.22-143.28-272.28-453.60-488.20
Accumulated Other Comprehensive Income0.070.00-0.150.000.00
Additional Paid-in Capital656.87610.27675.12640.10585.37
Shares Outstanding57.1456.7759.6258.830.00
Total Stockholders' Equity659.16466.99402.84186.5197.18
Total Liabilities & Equity999.20811.45673.87433.44427.07